Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Andrew G. McIntosh"'
Autor:
Courtney M. Chang, Andrew G. McIntosh, Daniel D. Shapiro, John W. Davis, John F. Ward, Justin R. Gregg
Publikováno v:
BJUI Compass, Vol 2, Iss 3, Pp 188-193 (2021)
Abstract Objective To define the value of a digital rectal exam (DRE) in the prostate‐magnetic resonance imaging (MRI) era. Prostate MRI is increasingly used in men with elevated prostate‐specific antigen (PSA) prior to biopsy. Methods A retrospe
Externí odkaz:
https://doaj.org/article/403455cc1d4e4e169a9f680bb800597f
Autor:
Victoria Gonzalez, Michael Suflita, Amanda Janitz, Janis Campbell, Andrew G. McIntosh, Kelly Stratton, Michael S. Cookson, Daniel C. Parker
Publikováno v:
Journal of Cancer Epidemiology, Vol 2022 (2022)
Purpose. This cohort study describes the differences in kidney cancer age-adjusted incidence and mortality rates between American Indians/Alaskan Natives (AI/ANs) and Whites in Oklahoma. Additionally, rates for the U.S. are updated to establish an ep
Externí odkaz:
https://doaj.org/article/34691bb124c5455db3207e58aaac8903
Publikováno v:
Transl Androl Urol
Unlike urothelial carcinoma of the bladder, there is no guideline-based consensus on whether a lymph node dissection (LND) should be performed at the time of radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Variable lymph
Publikováno v:
Indian Journal of Urology : IJU : Journal of the Urological Society of India
Indian Journal of Urology, Vol 37, Iss 1, Pp 13-16 (2021)
Indian Journal of Urology, Vol 37, Iss 1, Pp 13-16 (2021)
The management of metastatic renal cell carcinoma (mRCC) continues to be a therapeutic challenge; however, the options for systemic therapy in this setting have exploded over the past 20 years. From the advent of toxic cytokine therapy to the subsequ
Autor:
Aeen M, Asghar, Andrew G, McIntosh, Zachary L, Smith, Neil J, Kocher, Ziho, Lee, Nimrod N, Barashi, Tianyu, Li, Jay D, Raman, Scott E, Eggener, Robert G, Uzzo, Alexander, Kutikov
Publikováno v:
The Canadian journal of urology. 28(2)
To assess whether patients with a large renal mass, treated by radical nephrectomy (RN), could have benefited from preoperative renal mass biopsy (RMB). The decision to perform partial nephrectomy (PN) for an organ-confined4 cm renal mass can be comp
Autor:
Bryan Fellman, Andrew G. McIntosh, Luis A. Segarra, Curtis A. Pettaway, Eric C. Umbreit, Stephen B. Williams, Louis L. Pisters, Shi Ming Tu, John F. Ward, Jose A. Karam, Christopher G. Wood, Arun Z. Thomas, Chalairat Suk-Ouichai, Levi C. Holland
Publikováno v:
Cancer
BACKGROUND Postchemotherapy retroperitoneal lymphadenectomy (PC-RPLND) is an essential, yet potentially morbid, therapy for the management of patients with advanced germ cell tumors. In the current study, the authors sought to define the complication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa274ddea22a8a51a9978cc1490ca289
https://europepmc.org/articles/PMC9379780/
https://europepmc.org/articles/PMC9379780/
Autor:
John W. Davis, Daniel D. Shapiro, Courtney M. Chang, Andrew G. McIntosh, Justin R. Gregg, John F. Ward
Publikováno v:
BJUI Compass, Vol 2, Iss 3, Pp 188-193 (2021)
Objective To define the value of a digital rectal exam (DRE) in the prostate‐magnetic resonance imaging (MRI) era. Prostate MRI is increasingly used in men with elevated prostate‐specific antigen (PSA) prior to biopsy. Methods A retrospective stu
Autor:
Andrew G, McIntosh, Daniel C, Parker, Brian L, Egleston, Robert G, Uzzo, Mohammed, Haseebuddin, Shreyas S, Joshi, Rosalia, Viterbo, Richard E, Greenberg, David Y T, Chen, Marc C, Smaldone, Alexander, Kutikov
Publikováno v:
BJU Int
Journal of urology, 204(1). Elsevier Inc.
Journal of urology, 204(1). Elsevier Inc.
OBJECTIVES: To develop a clinically actionable predictive model to quantitate the risk of estimated glomerular filtration rate decline to ≤ 45 ml/min/1.73m(2) following radical nephrectomy in order to better inform decisions between radical and par
Autor:
Andrew G. McIntosh, Shi-Ming Tu
Publikováno v:
The Journal of urology. 203(6)
Autor:
Nizar M. Tannir, Cindy Gu, Christopher G. Wood, Surena F. Matin, Eric C. Umbreit, Andrew G. McIntosh, Levi C. Holland, Stephen H. Culp, Jose A. Karam
Publikováno v:
CancerReferences. 126(17)
BACKGROUND The management of metastatic renal cell carcinoma (mRCC) has evolved rapidly, and results from the Cancer du Rein Metastatique Nephrectomie et Antiangiogeniques (CARMENA) trial bring into question the utility of cytoreductive nephrectomy (